Does ARIPIPRAZOLE Cause Dyslipidaemia? 185 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Dyslipidaemia have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.3% of all adverse event reports for ARIPIPRAZOLE.
185
Reports of Dyslipidaemia with ARIPIPRAZOLE
0.3%
of all ARIPIPRAZOLE reports
0
Deaths
107
Hospitalizations
How Dangerous Is Dyslipidaemia From ARIPIPRAZOLE?
Of the 185 reports, 107 (57.8%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
PREDNISONE (148)
Which ARIPIPRAZOLE Alternatives Have Lower Dyslipidaemia Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE